https://en.sputniknews.africa/20241216/africas-gene-pool-a-critical-source-for-pharmaceutical-research--development--1069704442.html
Africa's Gene Pool: A Critical Source for Pharmaceutical Research & Development
Africa's Gene Pool: A Critical Source for Pharmaceutical Research & Development
Sputnik Africa
Three percent of global clinical trials happen in Africa, limiting research on how medicines interact with its genetic makeup. This imbalance hinders the... 16.12.2024, Sputnik Africa
2024-12-16T12:22+0100
2024-12-16T12:22+0100
2024-12-16T18:27+0100
african currents
podcasts
sputnik africa
africa
medicine
biomedicine
east africa
central africa
north africa
west africa
https://cdn1.img.sputniknews.africa/img/07e8/0c/10/1069737796_0:88:400:313_1920x0_80_0_0_5ae95ae290719b1fab5cc00170456567.jpg
Africa's Gene Pool: A Critical Source for Pharmaceutical Research & Development
Sputnik Africa
Three percent of global clinical trials happens in Africa, limiting research on how medicines interact with its genetic makeup. This imbalance hinders the development of treatments tailored to African populations, which could potentially revolutionize global health and improve the efficacy of medications worldwide.
How people respond to medicines often depends on their genetics, and Africa’s diversity plays a significant role. By focusing on drug discovery in Africa, researchers can address pressing health challenges specific to the continent, Kelly Chibale, a Professor of Organic Chemistry at the University of Cape Town and the founder and director of the H3D Research Center and H3D Foundation, told Sputnik Africa in an interview.Discover more insights from our guest on the African Currents podcast, proudly presented by Sputnik Africa.You can find our episodes not just on the website but also on Telegram.► You can also listen to our podcast on Apple Podcasts, Spotify, Deezer, Pocket Casts, Afripods, Podcast Addict.► Check out all the episodes of African Currents
africa
east africa
central africa
north africa
west africa
southern africa
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2024
Chimauchem Nwosu
https://cdn1.img.sputniknews.africa/img/07e8/06/0b/1066992175_0:0:278:278_100x100_80_0_0_b5f6eaa3b85dbfcd0266ea860848a996.jpg
Chimauchem Nwosu
https://cdn1.img.sputniknews.africa/img/07e8/06/0b/1066992175_0:0:278:278_100x100_80_0_0_b5f6eaa3b85dbfcd0266ea860848a996.jpg
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Chimauchem Nwosu
https://cdn1.img.sputniknews.africa/img/07e8/06/0b/1066992175_0:0:278:278_100x100_80_0_0_b5f6eaa3b85dbfcd0266ea860848a996.jpg
podcasts, sputnik africa, africa, medicine, biomedicine, east africa, central africa, north africa, west africa, southern africa, аудио
podcasts, sputnik africa, africa, medicine, biomedicine, east africa, central africa, north africa, west africa, southern africa, аудио
Africa's Gene Pool: A Critical Source for Pharmaceutical Research & Development
12:22 16.12.2024 (Updated: 18:27 16.12.2024) Three percent of global clinical trials happen in Africa, limiting research on how medicines interact with its genetic makeup. This imbalance hinders the development of treatments tailored to African populations, which could potentially revolutionize global health and improve the efficacy of medications worldwide.
How people respond to medicines often depends on their genetics, and Africa’s diversity plays a significant role. By focusing on drug discovery in Africa, researchers can address pressing health challenges specific to the continent, Kelly Chibale, a Professor of Organic Chemistry at the University of Cape Town and the founder and director of the H3D Research Center and H3D Foundation, told Sputnik Africa in an interview.
"Humans came from Africa [..]. The variability that we see in the way different people, populations, or individuals respond to medicines is a consequence of genetic differences in the expression and activity of what we call drug-metabolizing enzymes. There is a very strong link between the genetics of a population, the social and physical environment in which those patients live, and the treatment of disease. Therefore, building the drug discovery capability in close proximity to where the patients are in Africa is the best way to understand their real pressing unmet medical needs in their social and physical environment. That is one reason for doing drug discovery in Africa," Professor Chibale says.
Discover more insights from our guest on the African Currents podcast, proudly presented by Sputnik Africa.
You can find our episodes not just on the website but also on
Telegram.► Check out all the episodes of African Currents 
